FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Cell and Tissue Deviations at Palm Beach Fertility Center

FDA warns the Palm Beach Fertility Center about significant repeat deviations from cellular and tissue regulations.

latest-news-card-1
Medical Devices

FDA Criminal Probe Nets Device Maker Indictment

An FDA Office of Criminal Investigations probe leads to a Puerto Rico federal grand jury indictment against Magnetic Healer and three individuals char...

latest-news-card-1
Federal Register

Cell/Gene Therapy Advisory Committee Renewed

Federal Register notice: FDA announces the renewal of its Cellular, Tissue, and Gene Therapies Advisory Committee for an additional two years beyond i...

latest-news-card-1
FDA General

8 Inspection Takeaways from New FDA Law

Two former FDAers list eight key takeaways from the new FDA Omnibus Reform Act.

latest-news-card-1
Human Drugs

OCE Slowed New Projects in 2022

Oncology Center of Excellence director Richard Pazdur lists five activities for 2023 that build on steps taken in 2022.

latest-news-card-1
Human Drugs

Comments on FDA/Patent Office Collaboration

Four stakeholders respond to the patent offices request for comment on its proposed collaboration with FDA.

latest-news-card-1
Biologics

Kessler Praises Marks on Covid Response Leadership

CBER director Peter Marks gets high grades from former FDA commissioner and Biden administration Covid chief science officer David Kessler on Marks le...

latest-news-card-1
Marketing

Lower Added Benefit Associated with Higher DTC Spend

Johns Hopkins University researchers say spending on direct-to-consumer ads in 2020 was associated with drugs rated with lower added clinical benefit ...

latest-news-card-1
Human Drugs

Court Throws Out PhRMA Lawsuit on Drug Importation

The DC District Court dismisses for lack of standing a Pharmaceutical Research and Manufacturers of America-led lawsuit that sought to block HHS and F...

latest-news-card-1
Human Drugs

Roche Data on Crovalimab Met Primary Endpoints

A Roche Phase 3 study called COMMODORE 2 that was evaluating the efficacy and safety of crovalimab in certain people with paroxysmal nocturnal hemoglo...